Oramed Pharmaceuticals
ORMP
#9164
Rank
A$0.26 B
Marketcap
A$6.38
Share price
1.37%
Change (1 day)
71.49%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): A$95.26 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of A$89.52 Million, an increase over its 2024 earnings that were of -A$21.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$95.26 M6.41%
2025 A$89.52 M-513.21%
2024 -A$21.67 Million-311.47%
2023 A$10.24 M-119.45%
2022 -A$52.68 Million39.17%
2021 -A$37.85 Million73.93%
2020 -A$21.76 Million18.53%
2019 -A$18.36 Million-16.62%
2018 -A$22.02 Million38.32%
2017 -A$15.92 Million12.51%
2016 -A$14.15 Million25.01%
2015 -A$11.32 Million18.18%
2014 -A$9.58 Million39.72%
2013 -A$6.86 Million46.4%
2012 -A$4.69 Million128.32%
2011 -A$2.06 Million-51.47%
2010 -A$4.23 Million35.21%
2009 -A$3.13 Million
2007 -A$4.92 Million607.04%
2006 -A$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
A$33.39 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$10.29 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.73 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$87.89 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$50.16 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel